openPR Logo
Press release

Evans Syndrome: Projection of Each Major Segment, Drugs and Treatment over the Forecast Period,focusing on top key vendors like Pfizer, Merck & Co., Sanofi, Astellas Pharma, Inc., GlaxoSmithKline plc, Novartis AG

07-19-2018 03:45 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

Evans Syndrome Market

Evans Syndrome Market

Market Scenario

Evans syndrome (ES), is an autoimmune disorder characterized by the subsequent or simultaneous development of autoimmune hemolytic anemia, and immune thrombocytopenia. It is classified as primary or secondary based on its association with others diseases, such as primary antiphospholipid syndrome, systemic lupus erythematous (SLE), Sjögren syndrome, Hodgkin lymphoma, IgA deficiency, and chronic lymphocytic leukemia.

According to the Centers for Disease Control & Prevention, autoimmune disorder is the third most common category of disease in the United States after heart disease and cancer. It is reported that it affects approximately 5%–8% of the population i.e. 14–22 million persons.

The severity and symptoms of Evans syndrome vary greatly from one person to another. Some patients with Evans syndrome may first show the high destruction of red blood cells (RBCs), known as anemia, and others may first show low levels of platelets, known as thrombocytopenia. Low levels of white blood cells (WBSs), known as neutropenia, is less common in individuals with Evans syndrome than thrombocytopenia or anemia.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/5136

Notably, growing public awareness is the key factor driving the Evans syndrome market. Nowadays, people are becoming more aware of the different types of autoimmune disorders. Government and other different organizations have started educating people about hygiene and diseases through seminars, and conferences. People are becoming more aware and conscious of the diseases. Thus, increasing awareness has provided a push to the growth of the market.

Various other factors such as increasing incidents of autoimmune disorders, increasing government assistance, improving regulatory framework, increasing automation of laboratories and rising funding and reimbursement are continuously contributing to the growth of the global Evans syndrome market.

Despite these drivers, there are some issues associated with Evans syndrome market. Some of the challenges in research and development, side-effects of treatment, the presence of misbranded and spurious drugs, and poor healthcare system in low and middle-income countries, may hinder the growth of the market to an extent.

It is estimated that the Evans syndrome market is expected to grow at a CAGR 10.2% during the forecast period of 2017-2023.

Intended Audience

Pharmaceutical Companies
Research and Development (R&D) Companies
Diagnostic Laboratories
Government Research Institute
Academic Institutes and Universities
Segmentation

The global Evans syndrome market is segmented on the basis of diagnosis, treatment, and distribution channels.

On the basis of the diagnosis, the market is classified as blood test, bone marrow biopsy, antibody assays, computed tomography (CT) scan, flow cytometry of double-negative T cells, and others. The blood test is further segmented into complete blood count (CBC), and direct antiglobulin test.

On the basis of the treatment, the market is classified as pharmacologic therapy, splenectomy,

Biologic therapy, stem cell transplantation, and others. The pharmacologic therapy is further segmented into Prednisone and intravenous immunoglobulin (IVIg) therapy. The biologic therapy is segmented into Rituximab and others.

On the basis of the distribution channel, the market is segmented into hospitals, clinics, diagnostic centers, drug stores, pharmacies, and others.

Regional Analysis

The Americas dominate the Evans syndrome market owing to the rising awareness among people, and high healthcare expenditure. According to the Centers for Disease Control and Prevention in 2015, the total health expenditure in the United States was reported to be USD 3.2 trillion and hospital care accounted for a share of 32.3%.

Europe holds the second position in the Evans syndrome market. It is expected that the support provided by the government bodies for research & development and improvement in reimbursement policies in the healthcare is likely to drive the market of Europe region.

Asia Pacific is the fastest growing Evans syndrome market owing to a huge patient pool and developing healthcare technology. Healthcare expenditure is also improving in various Asia Pacific countries. According to the Australian Institute of Health and Welfare in the years 2015-2016, the total health expenditure was USD 170.4 billion, which is 3.6% higher than the expenditure of 2014-2015.

The Middle East & Africa holds the lowest market due to lack of technical knowledge and poor medical facilities.

Key Players

Some of key the players in the global Evans syndrome market are Pfizer, Merck & Co., Sanofi, Astellas Pharma, Inc., GlaxoSmithKline plc, Novartis AG, Enzon Pharmaceuticals, Inc., Bayer AG, Sigma-Aldrich, Abbott Laboratories, Eli Lily and Company, BD, ChemoMetec A/S, and Others.

Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/5136

Detailed Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
...Continued

Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/5136

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Evans Syndrome: Projection of Each Major Segment, Drugs and Treatment over the Forecast Period,focusing on top key vendors like Pfizer, Merck & Co., Sanofi, Astellas Pharma, Inc., GlaxoSmithKline plc, Novartis AG here

News-ID: 1136021 • Views:

More Releases from Market Research Future

Legg-Calve-Perthes Disease Market See Incredible Growth 2024-2031 | Non-Surgical Methods, Anti-Inflammatory Medications, Ibuprofen, Casting and Bracing
Legg-Calve-Perthes Disease Market See Incredible Growth 2024-2031 | Non-Surgical …
Legg-Calve-Perthes Disease Market Overview - The market for legg-calve-Perthes disease treatment is estimated to reach USD 400 million by 2030, growing at a CAGR of 4.60%. Legg-Calve-Perthes disease (LCPD) is a condition affecting the hip joint, primarily seen in children between the ages of 4 and 8. It occurs when blood flow to the femoral head (the "ball" of the hip joint) is temporarily disrupted, leading to bone death and potential deformity.
Passive Optical LAN Market Size, Share, Growth and Forecast to 2032
Passive Optical LAN Market Size, Share, Growth and Forecast to 2032
Passive Optical LAN Market Overview In today's digital age, where connectivity is paramount, the demand for robust and efficient network infrastructure continues to escalate. Traditional copper-based LAN (Local Area Network) systems are gradually being outpaced by newer, more advanced technologies. Among these innovations, Passive Optical LAN (POL) stands out as a game-changer. This article explores the burgeoning Passive Optical LAN market, its advantages, key drivers, and future prospects. Redefining Network Architecture with
Navigating Schizophrenia Care Market Expected to Expand to $8.06 Billion by 2030 | Johnson & Johnson, AstraZeneca, Eli Lilly, Alkermes
Navigating Schizophrenia Care Market Expected to Expand to $8.06 Billion by 2030 …
Schizophrenia Market Overview - The Schizophrenia Market Size was assessed at USD 5.5 billion in 2022 and is expected to expand from USD 5.76 billion in 2023 to USD 8.06 billion by 2030, with a compound annual growth rate (CAGR) of 4.9% during the forecast period (2023- 2030). The schizophrenia market is a significant segment within the pharmaceutical and mental healthcare industries, focused on addressing the complex needs of individuals living with
Revolutionizing Healing: Skin Graft Market Set to Grow at 7.01% CAGR, Reaching $7.36 Billion by 2032
Revolutionizing Healing: Skin Graft Market Set to Grow at 7.01% CAGR, Reaching $ …
Skin Graft Market Overview - In 2022, the skin graft market was estimated at USD 4.00 billion. The skin graft market is expected to increase from USD 4.28 billion in 2023 to USD 7.36 billion by 2032, with a compound annual growth rate (CAGR) of 7.01% over the forecast period (2023-2032). The skin graft market plays a crucial role in the field of dermatology and wound care, providing solutions for patients with

All 5 Releases


More Releases for Evans

Evans Midwest Completes & Ships First Countertop Cutting Station After Acquisiti …
(Holland, MI) Evans Midwest, manufacturer of countertop production machines and automated laminate lines, announced the shipment of the first Evans Midwest Countertop Cutting Station (CS-XLT). After acquiring the Countertop Division of Midwest Automation in mid-2018, Evans Midwest has tirelessly focused on developing an infrastructure to support existing countertop fabrication and laminating customers and producing the same time-tested machines the industry has grown to love. Over the years, the Evans Midwest Countertop
Marcus Evans Brings Together Experts to Redefine Strategic Road Networks
Jointly organised with International Road Federation, marcus evans proudly presents 4th Annual Roads & Highways conference happening from 19th to 21st April 2018 at Grand Copthorne Waterfront Hotel, Singapore. The conference aiming to provide a better understanding of the challenges, opportunities and risks related to infrastructure investment, how to integrate technical knowledge for the effective implementation and execution large scale projects. One of the speaker at the event shared insights on
Marcus Evans to Enable a Favorable Environment for Smart City Projects
Happening for the second time this year, Marcus Evans 2nd Annual Smart Cities is set to take place on the 25th – 27th October 2017 at Conrad Seoul, South Korea. Speaking at the event Fazal Hussain Director Enterprise Solutions City of Toronto mentioned that “sharing information from across the world allows us to consider new ideas and share experiences that help us all. The world is one big community the
Marcus Evans to Enable a Favorable Environment for Smart City Projects
Happening for the second time this year, Marcus Evans 2nd Annual Smart Cities is set to take place on the 25th – 27th October 2017 at Conrad Seoul, South Korea. Speaking at the event Fazal Hussain Director Enterprise Solutions City of Toronto mentioned that “sharing information from across the world allows us to consider new ideas and share experiences that help us all. The world is one big community the
Marcus Evans Brings in Experts to Reshape the Future of Africa
Marcus Evans proudly presents the 2nd Annual GRC Africa happening in Cape Town, South Africa from 10th – 12th July 2017. The conference will be bringing highly experience industry experts, world renowned thought leaders and an award winning trainer who are coming together under one platform to share and debate latest insights related to government, risk and compliance. The conference will be featuring experts exploiting application of data analytics and technology
Global Hybrid Supercapacitor Market 2017 : Ioxus Inc, Maxwell, Samwha & Evans
This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Ioxus Inc - Maxwell - Paper Battery - Samwha - Evans The survey report by Market Research Store is an overview of the global Hybrid Supercapacitor market. It covers all the recent trends including key developments in the global market in present and in future. Analyses of the global Hybrid Supercapacitor market trends along with